dc.contributor.author |
Nouri, Noura |
|
dc.contributor.author |
Garbe, Claus |
|
dc.date.accessioned |
2017-02-08T13:28:10Z |
|
dc.date.available |
2017-02-08T13:28:10Z |
|
dc.date.issued |
2016 |
|
dc.identifier.issn |
1744-7682 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/74362 |
|
dc.language.iso |
en |
en |
dc.publisher |
Taylor & Francis Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1517/14712598.2016.1157161 |
|
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Intralesional immunotherapy as a strategy to treat melanoma |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20160915142648_00874 |
|
utue.publikation.seiten |
619-626 |
de_DE |
utue.personen.roh |
Nouri, Noura |
|
utue.personen.roh |
Garbe, Claus |
|
dcterms.isPartOf.ZSTitelID |
Expert Opinion on Biological Therapy |
de_DE |
dcterms.isPartOf.ZS-Issue |
5 |
de_DE |
dcterms.isPartOf.ZS-Volume |
16 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
|